Recombinant multi-species ATG5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATG5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene, in combination with autophagy protein 12, functions as an E1-like activating enzyme in a ubiquitin-like conjugating system. The encoded protein is involved in several cellular processes, including autophagic vesicle formation, mitochondrial quality control after oxidative damage, negative regulation of the innate antiviral immune response, lymphocyte development and proliferation, MHC II antigen presentation, adipocyte differentiation, and apoptosis. Several transcript variants encoding different protein isoforms have been found for this gene. [provided by RefSeq, Sep 2015]
The Alternative Names of target: 2010107M05Rik,3110067M24Rik,APG5,APG5-LIKE,APG5-like,APG5L,ASP,ATG5,Apg5l,Apoptosis-specific protein,Atg5,Atg5l,Autophagy protein 5,Paddy,SCAR25,hAPG5
Go
to ATG5 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1410-Ag-1/ GM-Tg-hg-SE1410-Ag-2 | Human ATG5 protein | Human |
| GM-Tg-rg-SE1410-Ag-1/ GM-Tg-rg-SE1410-Ag-2 | Rat ATG5 protein | Rat |
| GM-Tg-mg-SE1410-Ag-1/ GM-Tg-mg-SE1410-Ag-2 | Mouse ATG5 protein | Mouse |
| GM-Tg-cynog-SE1410-Ag-1/ GM-Tg-cynog-SE1410-Ag-2 | Cynomolgus/Rhesus macaque ATG5 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1410-Ag-1/ GM-Tg-felg-SE1410-Ag-2 | Feline ATG5 protein | Feline |
| GM-Tg-cang-SE1410-Ag-1/ GM-Tg-cang-SE1410-Ag-2 | Canine ATG5 protein | Canine |
| GM-Tg-bovg-SE1410-Ag-1/ GM-Tg-bovg-SE1410-Ag-2 | Bovine ATG5 protein | Bovine |
| GM-Tg-equg-SE1410-Ag-1/ GM-Tg-equg-SE1410-Ag-2 | Equine ATG5 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1410-Ag-1/ GM-Tg-hg-SE1410-Ag-2;
GM-Tg-rg-SE1410-Ag-1/ GM-Tg-rg-SE1410-Ag-2;
GM-Tg-mg-SE1410-Ag-1/ GM-Tg-mg-SE1410-Ag-2; GM-Tg-cynog-SE1410-Ag-1/ GM-Tg-cynog-SE1410-Ag-2; GM-Tg-felg-SE1410-Ag-1/ GM-Tg-felg-SE1410-Ag-2; GM-Tg-cang-SE1410-Ag-1/ GM-Tg-cang-SE1410-Ag-2; GM-Tg-bovg-SE1410-Ag-1/ GM-Tg-bovg-SE1410-Ag-2; GM-Tg-equg-SE1410-Ag-1/ GM-Tg-equg-SE1410-Ag-2 |
| Products Name | ATG5 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ATG5 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ATG5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.